JP Morgan Chase’s Sharps Compliance Corp SMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,233
Closed -$54K 7164
2022
Q1
$54K Sell
9,233
-19,353
-68% -$122K ﹤0.01% 5773
2021
Q4
$203K Buy
28,586
+9,370
+49% +$71.9K ﹤0.01% 5346
2021
Q3
$159K Sell
19,216
-16,625
-46% -$155K ﹤0.01% 5353
2021
Q2
$369K Buy
35,841
+24,802
+225% +$345K ﹤0.01% 4888
2021
Q1
$159K Sell
11,039
-15,010
-58% -$193K ﹤0.01% 5234
2020
Q4
$246K Buy
26,049
+20,727
+389% +$158K ﹤0.01% 4735
2020
Q3
$34K Buy
5,322
+520
+11% +$3.78K ﹤0.01% 5053
2020
Q2
$34K Buy
+4,802
New +$34.1K ﹤0.01% 4940
2016
Q3
Sell
-5,217
Closed -$23K 4912
2016
Q2
$23K Buy
5,217
+100
+2% +$473 ﹤0.01% 4203
2016
Q1
$28K Buy
+5,117
New +$31K ﹤0.01% 4020

Other funds holding SMED

JP Morgan Chase's SMED Position: Q2 2022 in Review

JP Morgan Chase sold out of Sharps Compliance Corp (SMED) in Q2 2022, closing a stake of 9,233 shares — an estimated $54K sold.

JP Morgan Chase first reported a position in SMED in Q1 2016 and held it in 10 quarters. The position peaked at $369K in Q2 2021. 67 funds tracked by Wall St. Rank hold SMED as of Q2 2022.

  • JP Morgan Chase reported no remaining Sharps Compliance Corp position as of Q2 2022 after selling out during the quarter.
  • JP Morgan Chase sold 9,233 Sharps Compliance Corp shares in Q2 2022, an estimated $54K.
  • JP Morgan Chase first reported a position in Sharps Compliance Corp in Q1 2016 and held it in 10 quarters.
  • JP Morgan Chase's Sharps Compliance Corp position peaked at $369K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2022.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.